Mathew Benjamin Weimer, MD in Milton, WV - Medicare Family Practice

Mathew Benjamin Weimer, MD is a medicare enrolled "Family Medicine" physician in Milton, West Virginia. He went to Medical College Of Ohio and graduated in 2005 and has 19 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Valley Health Systems, Inc and his current practice location is 1347 Hillview Dr, Milton, West Virginia. You can reach out to his office (for appointments etc.) via phone at (304) 743-1407.

Mathew Benjamin Weimer is licensed to practice in West Virginia (license number 22530) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1245444074.

Contact Information

	Mathew Benjamin Weimer, MD
	1347 Hillview Dr, Milton, WV 25541-1513
	(304) 743-1407
	(304) 697-2086

Physician's Profile

Full Name	Mathew Benjamin Weimer
Gender	Male
Speciality	Family Practice
Experience	19 Years
Location	1347 Hillview Dr, Milton, West Virginia
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mathew Benjamin Weimer attended and graduated from Medical College Of Ohio in 2005

NPI Data:

NPI Number: 1245444074
Provider Enumeration Date: 05/10/2007
Last Update Date: 09/23/2019

Medicare PECOS Information:

PECOS PAC ID: 3577637081
Enrollment ID: I20121019000385

Medical Identifiers

Medical identifiers for Mathew Benjamin Weimer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245444074	NPI	-	NPPES
7100228730	Medicaid	KY
3810012382	Medicaid	WV
2849092	Medicaid	OH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	35.091875 (Ohio)	Secondary
207Q00000X	Family Medicine	22530 (West Virginia)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Amedisys Home Health Of West Virginia	Charleston, WV	Home health agency
St Mary's Medical Center	Huntington, WV	Hospital
Charleston Area Medical Center	Charleston, WV	Hospital
Cabell Huntington Hospital Inc	Huntington, WV	Hospital
Thomas Memorial Hospital	South charleston, WV	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Valley Health Systems, Inc	9931017969	53

News Archive

Down syndrome and Alzheimer's disease are the same

Nearly 20 years ago Huntington Potter kicked up a storm of controversy with the idea that Down syndrome and Alzheimer's were the same disease. Now the evidence is in: He was right.

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Following several years of significant growth, Medical Reimbursements of America (MRA) plans to consolidate locations and relocate its corporate headquarters in late February to a 70,000-square-foot facility in the Brentwood / Cool Springs area. Extensive renovations are currently being made to the new space, which formerly served as the Crescent Furniture showroom on Moore's Lane.

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Walgreen Co. and New York-based drugstore chain Duane Reade Holdings, Inc. today announced a definitive agreement under which Walgreens will acquire Duane Reade from affiliates of Oak Hill Capital Partners in a cash transaction for a total enterprise value of $1.075 billion, which includes the assumption of debt.

Lumizyme receives FDA approval for patients with late-onset Pompe disease

The U.S. Food and Drug Administration approved Lumizyme (alglucosidase alfa) for patients ages 8 years and older with late-onset (non-infantile) Pompe disease, a rare genetic disorder.

Entity Name	Valley Health Systems, Inc
Entity Type	Part B Supplier - Public Health/welfare Agency
Entity Identifiers	NPI Number: 1902962368 PECOS PAC ID: 9931017969 Enrollment ID: O20040325000411

Dr. Linda Ann Eakle, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1509 W Main Street, Milton, WV 25541 Phone: 304-743-7141 Fax: 304-743-7143
David Russell Ayers, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Harbour Way, Milton, WV 25541 Phone: 304-743-1407 Fax: 304-743-4516
Mr. Donald G Klinestiver, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1028 Mason St, Milton, WV 25541 Phone: 304-743-4244 Fax: 304-743-3124
Dr. Anita Tabor Dawson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1798 Midland Tr, Us Rt 60e, Milton, WV 25541 Phone: 304-743-5111 Fax: 304-743-9324
James Enochs, LPN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1417 Johns Creek Rd, Milton, WV 25541 Phone: 304-743-1407 Fax: 304-743-4516
Anthony Wayne Thacker, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1155 Main St, Milton, WV 25541 Phone: 304-743-8833 Fax: 304-743-8834

Mathew Benjamin Weimer, MD - Medicare Family Practice in Milton, WV

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Medicare Reassignments

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Down syndrome and Alzheimer's disease are the same

Medical Reimbursements of America to relocate to 70,000-square-foot facility

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Lumizyme receives FDA approval for patients with late-onset Pompe disease